iifl-logo-icon 1
iifl-logo-icon 1
iifl-logo-icon 1
Home

Piramal Pharma Ltd Board Meeting

₹157.36
(-1.26%)
Jul 4, 2024|03:32:07 PM

Piramal Pharma CORPORATE ACTIONS

05/07/2023calendar-icon
04/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting10 May 202430 Apr 2024
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2024 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the financial year ended 31st March 2024 and to consider recommending payment of dividend to the shareholders. Please refer attachment. (As per BSE Announcement Dated on 10/05/2024)
Board Meeting30 Jan 202417 Jan 2024
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 31st December 2023. Outcome of Board Meeting dated 30th January 2024 Unaudited Financial results (standalone & consolidated) for the quarter and nine months ended 31st December 2023 (As per BSE Announcement Dated on 30/01/2024)
Board Meeting27 Oct 202318 Oct 2023
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 inter alia to consider and approve A meeting of the Board of Directors of the Company will be held on Friday 27th October 2023 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended 30th September 2023. Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited (the Company) held on 27th October, 2023 Board Meeting Outcome - Results (As Per BSE Announcement dated on 27.10.2023)
Board Meeting3 Aug 202328 Jul 2023
Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2023 inter alia to consider and approve The Board of Directors of the Company will be held on Thursday 3rd August 2023 inter alia to consider the Unaudited Financial Results (Standalone and Consolidated) of the Company for quarter ended 30th June 2023. Outcome of the Meeting of the Board of Directors of Piramal Pharma Limited held on 3rd August, 2023 (As Per BSE Announcement Dated on 03.08.2023)

Piramal Pharma: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

QUICKLINKS FOR Piramal Pharma Ltd

Information
Share PriceFutures PriceOption Chain
Financials
Profit & LossBalance SheetCash FlowKey Ratios
Results
Quarterly ResultHalf Yearly ResultNine Monthly ResultAnnual Result
News
Company
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Marketplus
Derivativesplus
IPOplus
Mutual Fundsplus
Calculatorsplus
Nifty 50plus
Companyplus
Loansplus
Knowledge Centerplus
Newsplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

About
IIFL Group
Products & Services
Trading Documentation
Useful Links
ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.